• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • Clinical Trials GMP Management Specification for Drugs – Appendix (Draft) Issued

Clinical Trials GMP Management Specification for Drugs – Appendix (Draft) Issued

Clinical Trials GMP management
Saturday, 26 February 2022 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

Clinical Trials GMP Management Specification for Drugs – Appendix (Draft) Issued

Clinical trials GMP management specification first issued its draft in July 2018 aiming to help prepare drugs for clinical trials (including test drugs and placebo), and for changes in packaging and labeling for already marketed drugs as comparator and test drugs.

On January 18, 2022, the NMPA (National Medical Products Administration) issued the new appendix (draft) of the GMP (Good Manufacturing Practice) for drugs for clinical trials.

Key changes to previous clinical trials GMP management specification

  • Implementation of clinical batch release.
  • Applicant should establish a filing system by product category.
  • Standardize the changes in management during the clinical period.
  • Keep the intra- and inter-batch consistent for clinical trial drugs.
  • Clinical trial drugs require the risk assessment of collinearity and cleaning validation.
  • A complete sample retention management system for drugs used in clinical trials.

By Yu Fang and Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Clinical Trials, drug clinical trial, GMP, Good Manufacturing Practice, pharmaceuticals

What you can read next

China cosmetics adverse event monitoring system
Cosmetics Adverse Reaction Monitoring System has been launched in China
Extensive Update of the Implementation Rules for the CCC Certification of Automotive Parts
SAMR implements Administrative Measures for Product Quality Spot Inspections and Consumer Goods Recall Management for 2020

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.